- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
CellChorus Funding
CellChorus is active in the following markets / industries: biotechnology, pharmaceuticals, bioinformatics, artificial intelligence, bio pharm and artificial intelligence / machine learning. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on December 1, 2021.
Funding Rounds
PRE
Undisclosed amountPRE
Undisclosed amountPRE
Undisclosed amountInvestors of CellChorus
Asymmetry Ventures
Investing in scalable early-stage companies with exceptional defensibility
Rounds
PRE
Texas Halo Fund
Angel sidecar fund powered by the Houston Angel Network
Rounds
PRE
Y combinator created a new model for funding early stage startups
Rounds
PRE
Dan Meyer
CEO - CellChorus
co-founder - Pocketdoor
former COO Genospace (acq NYSE:HCA)
former investment team Arboretum Ventures & PJC.vc
